Fluoroquinolone antimicrobial agents in the treatment of prostatitis and recurrent urinary tract infections in men (original) (raw)
Drilica K, Zhao X: DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev 1997, 61:377–392. Google Scholar
Ehrlich-Gesellschaft P, Naber KG, Adam D: Classification of fluoroquinolones. Int J Antimicrob Agents 1998, 10:255–257. Article Google Scholar
Naber KG: Which fluoroquinolones are suitable for the treatment of urinary tract infections?Int J Antimicrob Agents 2001, 17:331–341. ArticlePubMedCAS Google Scholar
Workshop Committee of the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK): Chronic Prostatitis Workshop. Bethesda, MD: December 7–8, 1995.
Naber KG, Bergman B, Bishop MC, et al.: EAU Guidelines on Urinary and Male Genital Tract Infections. Njimegen, The Netherlands: European Association of Urology; 2001:1–75. Guidelines of the European Association of Urology on urinary and male genital tract infections. Concise statement about the treatment options. Google Scholar
Meares EM, Stamey TA: Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol 1968, 5:492–518. PubMedCAS Google Scholar
Krieger JN, Berger RE, Ross SO, et al.: Seminal fluid findings in men with nonbacterial prostatitis and prostatodynia. J Androl 1996, 17:310–318. PubMedCAS Google Scholar
Weidner W, Jantos C, Schiefer HG, et al.: Semen parameters in men with and without proven chronic prostatitis. Arch Androl 1991, 26:173–183. PubMedCAS Google Scholar
Weidner W, Schiefer HG, Krauss H, et al.: Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1461 patients. Infection 1991, 19(Suppl 3):119–125. Article Google Scholar
Naber KG, Weidner W. Prostatitis, epididymitis, and orchitis. In Infectious Diseases. Edited by Armstrong D, Cohen J. London: Mosby; 1999:1–58. Google Scholar
Stamey TA, Meares EM, Winningham G: Chronic bacterial prostatitis and the diffusion of drugs into the prostatic fluid. J Urol 1970, 103:187–194. PubMedCAS Google Scholar
Stamey TA: Urinary infection in males. In Urinary Infections. Baltimore: Williams and Wilkins; 1972:161. Google Scholar
Madsen PO, Whalen PR: Interaction between antimicrobial agents and prostatic tissue extract and fluid. Infection 1978, 6:75–77. ArticleCAS Google Scholar
Stamey TA, Bushby SR, Bragonje J: The concentration of trimethoprim in prostatic fluid: non-ionic diffusion or active transport?J Infect Dis 1973, 129Suppl:686–690. Google Scholar
Madsen PO, Kjaer TB, Baumeller A: Prostatic tissue and fluid concentrations of trimethoprim and sulfamethoxazole: experimental and clinical studies. Urology 1976, 8:129–132. ArticlePubMedCAS Google Scholar
Gasser TC, Larsen EH, Dorflinger T, Madsen PO: The influence of various body fluids and pH on E. coli MIC of quinolone derivatives. In Therapy of Prostatitis: Experimental and Clinical Data. Edited by Weidner W. Munich: Zuckschwerdt; 1986:50–53. Google Scholar
Sörgel F, Bulitta J, Kinzig-Schippers M: Pharmakokinetik der Chinolone. Chemotherapie J 2002, 11:25–33. Google Scholar
Naber KG, Kinzig M, Sörgel F, Weigel D: Penetration of ofloxacin into prostatic fluid, ejaculate, and seminal fluid. Infection 1993, 21:34–39. ArticlePubMedCAS Google Scholar
Naber KG, Sörgel F, Kinzig M, Weigel DM: Penetration of ciprofloxacin into prostatic fluid, ejaculate and seminal fluid in volunteers after an oral dose of 750 mg. J Urol 1993, 150:1718–1721. PubMedCAS Google Scholar
Naber KG: Role of quinolones in treatment of chronic bacterial prostatitis. In Quinolone Antimicrobial Agents, edn 2. Edited by Hooper DC, Wofson JS. Washington DC: American Society of Microbiology; 1993:285–297. Google Scholar
Naber CK, Steghafner M, Kinzig-Schippers M, et al.: Concentrations of gatifloxacin in plasma and urine and penetration into prostatic and seminal fluid, ejaculate, and sperm cells after single oral administration of 400 milligrams to volunteers. Antimicr Agents Chemother 2001, 45:293–297. ArticleCAS Google Scholar
Sörgel F, Kinzig, Naber KG: Physiological disposition of macrolides. In Macrolides: Chemistry, Pharmacology, and Clinical Uses. Edited by Bryskier AJ, Butzler JP, Neu HC, Tulkens PM. Paris: Arnette Blackwell; 1993:421–431. Google Scholar
Meares EM Jr: Prostatitis: a review. Urol Clin North Am 1975, 2:3–27. Google Scholar
Fair WR, Cordonnier JJ: The pH of prostatic fluid: a reappraisal and therapeutic implication. J Urol 1978, 120:695–698. PubMedCAS Google Scholar
Anderson RU, Fair WR: Physical and chemical determinations of prostatic secretion in benign hyperplasia, prostatitis, and adenocarcinoma. Invest Urol 1976, 14:137–140. PubMedCAS Google Scholar
Blacklock NJ, Beavis JP: The response of fluid pH in inflammation. Br J Urol 1978, 46:537–542. Google Scholar
Pfau A, Perlberg S, Shapiro A: The pH of the prostatic fluid in health and disease: implications of treatment in chronic bacterial prostatitis. J Urol 1978, 119:384–387. PubMedCAS Google Scholar
Naber KG, Madsen PO: Antibiotics: basic concepts. In Textbook of Prostatitis. Edited by Nickel JC. Oxford: Isis Medical Media; 1999:83–94. Review about pharmacokinetic concepts of antibiotics in prostatitis and summary of the most important clinical studies regarding treatment of chronic bacterial prostatitis. Google Scholar
Bulitta J, Kinzig-Schippers M, Naber CK, et al.: Limitations in the use of drug cocktails (DC) to compare the pharmacokinetics (PK) of drugs: ciprofloxacin (CIP) vs Levofloxacin (LEV). Poster presented at the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Toronto: September 17–20, 2000.
Png JC, Tan E, Foo KT, et al.: A comparative study of the distribution of ofloxacin and ciprofloxacin in prostatic tissue after simultaneous oral ingestion. Br J Urol 1997, 79:781–784. PubMedCAS Google Scholar
Park H, Lee T, Lee J, et al.: Simultaneous determination of levofloxacin and ciprofloxacin concentrations in serum and prostatic tissue [abstract #3291]. Presented at the 20th International Congress of Chemotherapy. Sydney: June 29-July 3, 1997.
Naber KG, Giamarellou H: Proposed study design in prostatitis. Infection 1994, 22:59–60. Article Google Scholar
Schaeffer AJ, Darras FS: The efficacy of norfloxacin in the treatment of chronic bacterial prostatitis refractory to trimethoprim-sulfamethoxazole and/or carbenicillin. J Urol 1990, 144:690–693. PubMedCAS Google Scholar
Petrikkos G, Peppas T, Giamarellou H, et al.: Four-year experience with norfloxacin in the treatment of chronic bacterial prostatitis [Abstract #1302]. Presented at the 17th International Congress of Chemotherapy. Berlin: June 27, 1991.
Pust RA, Ackenheil-Koppe HR, Gilbert P, Weidner W: Clinical efficacy of ofloxacin (Tarivid) in patients with chronic bacterial prostatitis: preliminary results. J Chemother 1989, 1:469–471. Google Scholar
Weidner W, Schiefer HG, Dalhoff A: Treatment of chronic bacterial prostatitis with ciprofloxacin: results of a 1-year followup study. Am J Med 1987, 82:280–283. PubMedCAS Google Scholar
Weidner W, Schiefer HG, Brahler E: Refractory chronic bacterial prostatitis: a re-evaluation of ciprofloxacin treatment after a median follow-up of 30 months. J Urol 1991, 146:350–352. PubMedCAS Google Scholar
Pfau A: Therapie der unteren Harnwegsinfektionen beim Mann unter besonderer Berücksichtigung der chronischen bakteriellen Prostatitis. Akt Urol 1987, 18:31–33. Article Google Scholar
Pfau A: The treatment of chronic bacterial prostatitis. Infection 1991, 19:160–164. Article Google Scholar
Naber KG, Busch W, Focht J, the German Prostatitis Study Group: Ciprofloxacin in the treatment of chronic bacterial prostatitis: a prospective, non-comparative, multicentre clinical trial with long-term follow-up. Int J Antimicrob Agents 2000; 14:143–149. ArticlePubMedCAS Google Scholar
Naber KG, the European Lomefloxacin Prostatitis Study Group: Lomefloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis. Int J Antimicrob Agents 2002, 20:18–27. ArticlePubMedCAS Google Scholar
Litwin MS, McNaughton-Collins M, Fowler FJ Jr, et al.: National Institutes of Health Chronic Prostatitis Symptom Index: development and validation of new outcome measure. J Urol 1999, 162:369–375. ArticlePubMedCAS Google Scholar
Naber KG: Antibiotic treatment of chronic bacterial prostatitis. In Textbook of Prostatitis. Edited by Nickel JC. Oxford: Isis Medical Media; 1999:285–292. Google Scholar
Bjerklund Johansen TE, Grüneberg RN, Guibert J, et al.: The role of antibiotics in the treatment of chronic prostatitis: a consensus statement. Eur Urol 1998, 34:457–466. Article Google Scholar
Mayersak JS: Transurethral ultrasonography directed intraprostatic injection of gentamycin-xylocaine in the management of the benign painful prostate syndrome: a report of a 5-year clinical study of 75 patients. Int Surg 1998, 83:347–349. PubMedCAS Google Scholar
Jimenez Cruz JF, Boronat F, Gallego J: Treatment of chronic prostatitis: intraprostatic injection under echography control. J Urol 1988, 139:967–970. Google Scholar
De la Rosette JJ, Hubregste MR, Meuleman EJH, et al.: Diagnosis and treatment of 409 patients with prostatitis syndromes. Urology 1993, 41:301–307. ArticlePubMed Google Scholar
Ohkawa M, Yamaguchi K, Tokunaga S, et al.: Antimicrobial treatment for chronic prostatitis as a means of defining the role of Ureaplasma urealyticum. Urol Int 1993, 51:129–132. ArticlePubMedCAS Google Scholar
Vorland LH, Carlson K, Aalen O: An epidemiological survey of urinary tract infections among outpatients in Northern Norway. Scand J Infect Dis 1985, 17:277–283. PubMedCAS Google Scholar
Barnes RC, Daifuku R, Roddy RE, Stamm WE: Urinary tract infection in sexually active homosexual men. Lancet 1986, 1:171–173. ArticlePubMedCAS Google Scholar
Spach DH, Stapelton AE, Stamm WE: Lack of circumcision increases the risk of urinary tract infection in young men. JAMA 1992, 267:679–681. ArticlePubMedCAS Google Scholar
Krieger JN, Ross SO, Simson JM: Urinary tract infections in healthy university men. J Urol 1993, 149:1046–1048. PubMedCAS Google Scholar
Ulleryd P, Zackrisson B, Aus G, et al.: Selective urological evaluation in men with febrile urinary tract infection. BJU Int 2001, 88:15–20. ArticlePubMedCAS Google Scholar
Hoepelman AI, van Buren M, van den Broeck J, Borleffs JC: Bacteriuria in men infected with HIV-1 is related to their immune status (CD4+ cell count). AIDS 1992, 6:179–184. ArticlePubMedCAS Google Scholar
Smith JW, Jones SR, Reed WP, et al.: Recurrent urinary tract infections in men. Ann Intern Med 1979, 91:544–548. PubMedCAS Google Scholar
Sabbaj J, Hoagland VL, Cook T: Norfloxacin versus co-trimoxazole in the treatment of recurring urinary tract infections in men. Scand J Infect Dis 1986, 48:48–53. CAS Google Scholar
Lipsky BA: Urinary tract infection in men: epidemiology, pathophysiology, diagnosis, and treatment. Ann Intern Med 1989, 110:138–150. PubMedCAS Google Scholar
Ulleryd P, Zackrisson B, Aus G, et al.: Prostatic involvement in men with febrile urinary tract infection as measured by serum prostate-specific antigen and transrectal ultrasonography. BJU Int 1999, 84:470–474. ArticlePubMedCAS Google Scholar
Blacklock NJ: The anatomy of the prostate: relationship with prostatic infection. Infection 1991, 19(Suppl 3):S111-S114. ArticlePubMed Google Scholar
Gleckman R, Crowely M, Natsios GA: Recurrent urinary tract infections in men: an assessment of contemporary treatment. Am J Med Sci 1980, 279:31–36. ArticlePubMedCAS Google Scholar
Schaeffer AJ: Review of norfloxacin in complicated and recurrent urinary tract infections. In Symposium: New Insights into the Clinical Profile of Norfloxacin. Taormina, Italy: May 23, 1988.
Ulleryd P, Sandberg T: Ciprofloxacin for 2 or 4 weeks in the treatment of febrile urinary tract infection in men: a randomized trial with a 1-year follow-up. Scand J Infect Dis 2003, 35:34–39. ArticlePubMed Google Scholar
Biering-Sorensen F, Hoiby N, Nordenbo A, et al.: Ciprofloxacin as prophylaxis for urinary tract infections: prospective, randomized, cross-over, placebo-controlled study in patients with spinal cord lesion. J Urol 1994, 151:105–108. PubMedCAS Google Scholar
Van der Wall E, Verkooyen RP, Mintjes-De Groot J, et al.: Prophylactic ciprofloxacin for catheter-associated urinary tract infection. Lancet 1992, 339:946–951. ArticlePubMed Google Scholar